Login / Signup

Maternal hyperoxygenation: A potential therapy for congenital heart disease in the fetuses? A systematic review of the current literature.

Jennifer G Co-VuDalia Lopez-ColonHimesh V VyasNatalie WeinerCurt DeGroff
Published in: Echocardiography (Mount Kisco, N.Y.) (2018)
The current evidence for MH therapy suggests an increase in pulmonary blood flow, and venous return, ductal flow, and heart dimensions in fetuses. MH has potential as a diagnostic and therapeutic tool in fetuses with CHD. Further randomized controlled trials are needed to ascertain whether MH therapy provides improved outcomes on fetuses with certain types of CHD.
Keyphrases